Volume 12, Number 6—June 2006
Research
Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season
Figure

Figure. Dendrogram of Staphylococcus aureus isolates determined by using SmaI–digested DNA recovered from patients with community-acquired pneumonia associated with influenzalike illness, influenza season, 2003–04. NA, not applicable (methicillin-susceptible); SE, staphylococcal enterotoxin A, B, C, H; REF, reference strain; PVL, Panton-Valentine leukocidin; TSST, toxin shock syndrome toxin; CHL, chloramphenicol; CLI, clindamycin; ERY, erythromycin; GM, gentamicin; LEV, levofloxacin; OX, oxacillin; PEN, penicillin; TET, tetracycline. *Inducible clindamycin resistance.
Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.